About Laxxon Medical Laxxon Medical operates as a pharma-technology company that offers 3D screen printing in the pharmaceutical industry. The company offers advanced patented generics, patent extension, technology transfer, research and development, commercialization, new drug development, and 3D screen ...
赢创宣布通过其风险投资部门投资美国医药企业Laxxon Medical。该公司开发了一种3D丝网印刷技术，可用于生产使活性药物成分定时释放的结构化药片，并且单个药片可含有多种活性成分。赢创的特种聚合物可确保这种新型药片中的活性成分在体内实现靶向传递。赢创风险投资负责人Bernhard Mohr表示：“这项技术对患者非常有益。更可控...
“Laxxon’s partnership with Adare represents a significant step forward in actualizing our mission to drive disruptive global drug delivery and manufacturing solutions,” added Helmut Kerschbaumer, CEO of Laxxon Medical. “This is an essential collaboration for Laxxon; Adare, with their CDMO expe...
COO of Laxxon Medical. “This partnership will serve as a great accelerator in establishing 3D screen printing within the pharmaceutical industry thus accelerating our ability to serve our customers.”“Hovione has a global reputation for their pharmaceutical...
德国化学公司赢创的风险投资部门投资了总部位于内华达州的3D打印制药公司 Laxxon Medical,以使3D打印药片的大规模生产更接近现实。 两家公司正在合作使用 Laxxon 的专利3D丝网印刷技术和赢创的专用聚合物材料来批量制造新型多药片剂。该合作伙伴关系的目的是改善患者的药物输送,同时推进3D打印药物的商业化。